Lung Cancer: 854 Real Stories

854 stories match lung cancer. 428 of them mention chemotherapy.

Cancer Stories

A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

Lung cancer surgery complicated by a delayed tracheal tear

Patient Info: Anonymized, male, 70+

He died 37 days after lung-cancer surgery following a prolonged postoperative course complicated by bleeding, a tracheal tear and progressive respiratory and hemodynamic deterioration.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage II Lung Squamous Cell CarcinomaLung Cancer

Delayed adrenal insufficiency after lung cancer immunotherapy

Patient Info: Anonymized, male, 60s | Stage II

Imaging and bronchoscopy in November 2024 showed no lung-cancer recurrence or metastasis. By June 2026, he had not experienced another adrenal crisis while continuing hormone replacement.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

More than 5 years living with metastatic lung adenocarcinoma after stepwise molecular testing

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: HER2 amplification, EGFR L858R mutation, PD-L1 <1%

Metastatic Site: brain, lung

As of April 2026, she remained on gefitinib with no active tumor lesions after complete regression of lung metastases, more than 5 years (66 months) after her original diagnosis.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Lung Squamous Cell CarcinomaLung Cancer

EGFR-mutated Stage IV squamous lung cancer treated with osimertinib

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: EGFR L858R mutation; PD-L1 TPS 5%

Metastatic Site: pleura, bone

Osimertinib produced an early partial response, but new vertebral bone metastases appeared after 12 weeks. He declined cytotoxic chemotherapy and continued osimertinib.

PubMed Central
OutcomeSetback / Progression
Lorie, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Lorie's Patient Story

Patient Info: Lorie Young | Stage IV

Biomarkers: NTRK1 fusion

After a couple of months on TL-118, Lorie’s CT scan showed a strong response, while longer-term disease control remained uncertain.

MD Anderson
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Severe blood-clotting disorder, liver injury, and reversible kidney injury during treatment for Stage IV lung cancer

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: PD-L1 about 1%; KRAS mutation

Metastatic Site: bone (right 4th and 5th ribs)

Restaging before cycle 4 showed a partial response. Cancer treatment was then interrupted as severe acquired iTTP, cholestatic liver injury, and reversible acute kidney injury required intensive management.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Lung cancer first discovered after a small-bowel blockage

Patient Info: Anonymized, Male, 50s | Stage IV

Metastatic Site: jejunum|brain|bone

The cancer progressed to the brain and spine despite chemotherapy, and he was admitted to palliative care.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Stage III Lung Squamous Cell CarcinomaLung Cancer

Stage IIIB lung cancer: heart inflammation from durvalumab immunotherapy, mistaken at first for tumor spreading to the heart

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: No actionable driver mutations identified; PD-L1 tumor proportion score <1%

She recovered cardiac function after treatment for durvalumab-associated myocarditis and remained without lung-cancer relapse or cardiac decline for more than 4 years, with no additional anticancer therapy.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Long-term lung cancer control after immunotherapy-related diabetes

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: PD-L1 80%; EGFR, ALK, ROS1 and BRAF negative

Metastatic Site: brain|liver

After years of disease control off pembrolizumab, a new brain lesion appeared in December 2025 and was treated with focused radiation. He remained clinically stable under oncology follow-up.

PubMed Central
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

MET-Positive Lung Cancer Found After Eye Pain and Forehead Swelling

Patient Info: Anonymized, Male | Stage IV

Biomarkers: MET exon 14 skipping mutation

Metastatic Site: Right orbit; frontal skull/bone; left iliac bone

After 2 months of tepotinib, the primary lung lesion decreased from about 53 × 33 mm to 36 × 24 mm, metastatic sites were stable and the patient continued treatment without significant adverse events.

PubMed Central
OutcomeStable Disease / Ongoing Therapy
Dave, who was diagnosed with Stage I Lung CancerLung Cancer

Dave Bjork’s Stage 1 Lung Cancer Story

Patient Info: Dave Bjork, Male | Stage I

Dave survived more than 20 years after surgery for stage I lung cancer and became an advocate for early detection, screening and inclusion of early-stage survivors.

The Patient Story
OutcomeCancer-Free / Long-Term Survivor
Anne, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV EGFR Lung Cancer: Anne's Patient Story

Patient Info: Anne, Female | Stage IV

Biomarkers: EGFR-positive

Metastatic Site: spine; hips; lymph nodes; liver

Anne maintained a good quality of life for about 1 year on an oral EGFR-targeted medicine and later entered a clinical trial while continuing lung-cancer advocacy.

The Patient Story
OutcomeLiving With Cancer / Clinical Trial
Jeff, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV ALK Lung Cancer: Jeff's Patient Story

Patient Info: Jeff Meckstroth, Male | Stage IV

Biomarkers: ALK-positive driver mutation

Metastatic Site: Brain

More than 6 years after an initial prognosis of about 6 months, Jeff was alive, preparing to retire and continuing biomarker-guided care; the brain metastases had disappeared within a few months of the therapy change.

The Patient Story
OutcomeLiving With Cancer / Ongoing Therapy
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

RET-positive Stage IV lung cancer: targeted therapy stopped after severe side effects

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: RET fusion

Metastatic Site: brain|bone

Selpercatinib produced early shrinkage of the lung tumor and brain metastases, but it was permanently discontinued because of recurrent severe side effects. She was transferred for supportive care.

PubMed Central
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Lung adenocarcinoma that spread to the thyroid 9 years later

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: thyroid

After the thyroid metastasis was removed, she started systemic chemotherapy and remained under oncology management.

PubMed Central
OutcomeCare Ongoing
Heidi, who was diagnosed with Stage III Lung AdenocarcinomaLung Cancer

Stage III Lung Adenocarcinoma: Heidi's Survivor Story

Patient Info: Heidi Nafman-Onda, Female, 50s | Stage III

Heidi described living 3 years after a Stage III lung adenocarcinoma diagnosis with a high quality of life and became a lung cancer awareness advocate through The White Ribbon Project.

The Patient Story
OutcomeSurvivorship / Completed Treatment